This inventor holds 1 USPTO granted patent. Top assignee: Societe Des Produits Nestle S.a.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Charlotte Macron and a Patent for Early Detection of Feline Kidney Disease.
Introduction
Charlotte Macron is an inventor associated with Lausanne, Switzerland, and Société des Produits Nestlé S.A. Her patent work addresses the diagnosis and potential treatment of chronic kidney disease in cats.
Latest Patents
Macron is associated with 1 patent, titled “Compositions and Methods for Diagnosing and/or Treating Chronic Kidney Disease.” The invention describes using circulating proteins as markers to help identify early-stage chronic kidney disease in felines. It outlines measuring one or more proteins—including adiponectin, cathelicidin, kinesin-like protein, retinol-binding protein, and coagulation factor X—and comparing their amounts with predetermined values or ranges to assess whether a cat has early-stage disease.
Career Highlights
The patent reflects work at the intersection of veterinary diagnostics and biomarker research. By focusing on measurable proteins in feline blood, the disclosed approach aims to support earlier identification of chronic kidney disease.
Collaborations
Macron’s listed coworkers include Qinghong Li and Loïc Dayon. The patent is associated with Société des Produits Nestlé S.A.
Conclusion
Charlotte Macron’s patent work centers on protein-based methods for diagnosing early-stage chronic kidney disease in cats, contributing to research into veterinary health and diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
